Protagonist Therapeutics, Inc (PTGX) stock
PTGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/30199% above fair value
$127.16+2.49 (+2.00%)
Close on Nov 18, 2026Market cap $8.23BP/E 123.5Yield –
Protagonist Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Protagonist Therapeutics's market cap was $8.72B on Nov 11, 2026, against $5.62B a year earlier. Over the last 5 years it ranged from $384.05M to $9.56B, with a median of $2.03B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $8.72B | +59.9% |
| 2025 | Dec 31, 2025 | $5.45B | +137.4% |
| 2024 | Dec 31, 2024 | $2.30B | +73.8% |
| 2023 | Dec 29, 2023 | $1.32B | +146.3% |
| 2022 | Dec 30, 2022 | $536.75M | -67.1% |
| 2021 | Dec 31, 2021 | $1.63B | +116.7% |
| 2020 | Dec 31, 2020 | $752.27M | +292.2% |
| 2019 | Dec 31, 2019 | $191.81M | +18.1% |
| 2018 | Dec 31, 2018 | $162.45M | -53.9% |
| 2017 | Dec 29, 2017 | $352.44M | -4.1% |
| 2016 | Dec 30, 2016 | $367.55M | – |
See a number that looks wrong?